BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10831361)

  • 1. Management of uterine Müllerian adenosarcoma with extrauterine metastatic deposits.
    Guidozzi F; Smith T; Koller AB; Reinecke L
    Gynecol Oncol; 2000 Jun; 77(3):464-6. PubMed ID: 10831361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Uterine adenosarcoma. Apropos of a case of uterine and vaginal adenosarcoma with a corrected genital prolapse].
    Kabwa L; Mattei JP; Eloit S; Ramadane A; Grange B
    J Chir (Paris); 1997 Jul; 134(2):80-5. PubMed ID: 9378790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of 105 cases with uterine sarcoma.
    Yoney A; Eren B; Eskici S; Salman A; Unsal M
    Bull Cancer; 2008 Mar; 95(3):E10-7. PubMed ID: 18390406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine papillary serous carcinoma: patterns of failure and survival.
    Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis and treatment of Mullerian adenosarcoma of the uterus.
    Shi Y; Liu Z; Peng Z; Liu H; Yang K; Yao X
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):596-600. PubMed ID: 19133051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant mixed Mullerian tumours of the uterus--a ten-year experience.
    Ho SP; Ho TH
    Singapore Med J; 2002 Sep; 43(9):452-6. PubMed ID: 12568422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two unusual presentations of müllerian adenosarcoma: case reports, literature review, and treatment considerations.
    Gollard R; Kosty M; Bordin G; Wax A; Lacey C
    Gynecol Oncol; 1995 Dec; 59(3):412-22. PubMed ID: 8522267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
    Gallardo A; Prat J
    Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T;
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.
    Low JS; Wong EH; Tan HS; Yap SP; Chua EJ; Sethi VK; Soh LT; Low J; Tay EH; Chew SH
    Gynecol Oncol; 2005 Apr; 97(1):171-7. PubMed ID: 15790454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian conservation in a woman of reproductive age with müllerian adenosarcoma.
    Michener CM; Simon NL
    Gynecol Oncol; 2001 Nov; 83(2):424-7. PubMed ID: 11606111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of 12 cases of uterine carcinosarcoma].
    Wang LH; Xiong Y; Li YF; Li JD; Feng YL; Li YJ; Chen C; Chen L
    Ai Zheng; 2008 May; 27(5):516-9. PubMed ID: 18479602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
    Dusenbery KE; Potish RA; Judson P
    Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary vaginal adenosarcoma with sarcomatous overgrowth.
    Toyoshima M; Akahira J; Moriya T; Hayakawa S; Yaegashi N
    Gynecol Oncol; 2004 Dec; 95(3):759-61. PubMed ID: 15582000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological analysis of mullerian adenosarcoma of the uterus.
    Han XY; Xiang Y; Guo LN; Shen K; Wan XR; Huang HF; Pan LY
    Chin Med J (Engl); 2010 Mar; 123(6):756-9. PubMed ID: 20368100
    [No Abstract]   [Full Text] [Related]  

  • 20. Multimodality therapy for patients with clinical Stage I and II malignant mixed Müllerian tumors of the uterus.
    Manolitsas TP; Wain GV; Williams KE; Freidlander M; Hacker NF
    Cancer; 2001 Apr; 91(8):1437-43. PubMed ID: 11301390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.